Zobrazeno 1 - 10
of 32
pro vyhledávání: '"David W. Hines"'
Autor:
Russell M. Petrak, Nathan C. Skorodin, Nicholas W. Van Hise, Robert M. Fliegelman, Jonathan Pinsky, Vishal Didwania, Michael Anderson, Melina Diaz, Kairav Shah, Vishnu V. Chundi, David W. Hines, Brian P. Harting, Kamo Sidwha, Brian Yu, Paul Brune, Anjum Owaisi, David Beezhold, Joseph Kent, Dana Vais, Alice Han, Neethi Gowda, Nishi Sahgal, Jan Silverman, Jonathan Stake, Jenie Nepomuceno, Renuka Heddurshetti
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 6, Pp 2146-2151 (2021)
Tocilizumab is an IL‐6 receptor antagonist with the ability to suppress the cytokine storm in critically ill patients infected with severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2). We evaluated patients treated with tocilizumab f
Externí odkaz:
https://doaj.org/article/8f2e979c953546579043c6871302879b
Autor:
Guillermo Rodriguez-Nava, MD, Maria Adriana Yanez-Bello, MD, Daniela Patricia Trelles-Garcia, MD, Chul Won Chung, MD, Sana Chaudry, MD, Aimen S. Khan, MD, Harvey J. Friedman, MD, FACP, David W. Hines, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 1, Pp 1-10 (2021)
Objective: To describe the clinical characteristics, outcomes, and risk factors for death of patients with coronavirus disease 2019 (COVID-19) in a community hospital setting. Patients and Methods: This single-center retrospective cohort study includ
Externí odkaz:
https://doaj.org/article/b5a4870e998b4e66905a3cada264dbc6
Autor:
Guillermo Rodriguez-Nava, Maria Adriana Yanez-Bello, Daniela Patricia Trelles-Garcia, Chul Won Chung, Harvey J. Friedman, David W. Hines
Publikováno v:
International Journal of Infectious Diseases, Vol 102, Iss , Pp 571-576 (2021)
Objective: To evaluate the performance of the Quick COVID-19 Severity Index (qCSI) and the Brescia-COVID Respiratory Severity Scale (BCRSS) in predicting intensive care unit (ICU) admissions and in-hospital mortality in patients with coronavirus dise
Externí odkaz:
https://doaj.org/article/12b0baea4fb741788a2509babf0b78f6
Autor:
Russell M. Petrak, MD, Nicholas W. Van Hise, PharmD, Nathan C. Skorodin, PharmD, Robert M. Fliegelman, DO, Vishnu Chundi, MD, Vishal Didwania, MD, Alice Han, MD, Brian P. Harting, MD, David W. Hines, MD
Publikováno v:
Critical Care Explorations, Vol 3, Iss 4, p e0395 (2021)
Objectives:. To identify the most efficacious timing for tocilizumab administration in critically ill patients infected with severe acute respiratory syndrome coronavirus-2. Design:. Observational multicenter cohort study. Setting:. A total of 23 acu
Externí odkaz:
https://doaj.org/article/7249c69e1d3e407f88817361f0fd5948
Autor:
Nicholas W. Van Hise, Robert M. Fliegelman, Vishnu Chundi, Russell M. Petrak, Nathan C. Skorodin, Brian P. Harting, Vishal Didwania, David W. Hines, Alice Han
BackgroundSARS-CoV-2 is a novel coronavirus that has rapidly expanded to become a pandemic, resulting in millions of deaths worldwide. The cytokine storm is caused by the release of inflammatory agents and results in a physiologic disruption. Tociliz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30fdd36a7c2ad41d937b78ecead97e27
https://doi.org/10.1101/2020.10.27.20211433
https://doi.org/10.1101/2020.10.27.20211433
Autor:
Nicholas W. Van Hise, Vishal Didwania, Ingrid Roig, Robert M. Fliegelman, Russell M. Petrak, Kairav Shah, Michael Anderson, Alice Han, Vishnu Chundi, David W. Hines, Apoorv Kalra, Nathan C. Skorodin
Publikováno v:
Infectious Diseases and Therapy
Infectious Diseases and Therapy, Vol 9, Iss 4, Pp 1017-1028 (2020)
Infectious Diseases and Therapy, Vol 9, Iss 4, Pp 1017-1028 (2020)
Background Eravacycline is a novel fluorocycline approved for treatment of intraabdominal infections, with a broad spectrum of activity against a range of pathogens including multidrug-resistant species, including ESBL- or KPC-producing isolates. It
Autor:
Nicholas W. Van Hise, Vishnu Chundi, Neethi Gowda, Vishal Didwania, Jonathan Stake, Brian Yu, Kamo Sidwha, Nishi Sahgal, Michael Anderson, Paul Brune, Joseph Kent, Dana Vais, Jenie Nepomuceno, David W. Hines, Alice Han, Renuka Heddurshetti, Jan Silverman, Melina Diaz, Brian P. Harting, Russell M. Petrak, Kairav Shah, Anjum Owaisi, Jonathan Pinsky, Nathan C. Skorodin, Robert M. Fliegelman, David Beezhold
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 14, Iss 6, Pp 2146-2151 (2021)
Clinical and Translational Science, Vol 14, Iss 6, Pp 2146-2151 (2021)
BackgroundTocilizumab is an IL-6 receptor antagonist with the ability to suppress the cytokine storm in critically ill patients infected with SARS-CoV-2.MethodsWe evaluated patients treated with tocilizumab for a SARS-CoV-2 infection who were admitte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f8f0b99ab355743cbcb5ee6df91a382
https://doi.org/10.1101/2020.06.05.20122622
https://doi.org/10.1101/2020.06.05.20122622
Autor:
Robert A. Weinstein, Yoona Rhee, Shayna Weiner, Manon R. Haverkate, Michael Y. Lin, Nicholas M. Moore, Karen Lolans, Mary K. Hayden, Louis Fogg, Koh Okamoto, David W. Hines, Sarah K Kemble, Donald Blom, Rosie D. Lyles
Publikováno v:
Infect Control Hosp Epidemiol
Infection control and hospital epidemiology, 38(6), 670. University of Chicago Press
Infection control and hospital epidemiology, 38(6), 670. University of Chicago Press
OBJECTIVETo identify modifiable risk factors for acquisition ofKlebsiella pneumoniaecarbapenemase-producing Enterobacteriaceae (KPC) colonization among long-term acute-care hospital (LTACH) patients.DESIGNMulticenter, matched case-control study.SETTI
Autor:
Maria Adriana Yanez-Bello, Harvey Friedman, David W. Hines, Chul Won Chung, Daniela Patricia Trelles-Garcia, Guillermo Rodriguez-Nava, Sana Chaudry, Aimen S. Khan
Publikováno v:
Open Forum Infectious Diseases
Background As the ongoing COVID-19 pandemic develops, there is a need for prediction rules to guide clinical decisions. Previous reports have identified risk factors using statistical inference model. The primary goal of these models is to characteri
Autor:
Mabel Frias, Sarah K Kemble, George Markovski, Rachel B. Slayton, Erica Runningdeer, John A. Jernigan, Jinal Makhija, Pamela Bell, Nimalie D. Stone, Sarah M. Bartsch, Sujan C. Reddy, Alice Han, Massimo Pacilli, Olufemi Jegede, Angela S Tang, David W. Hines, Bruce Y. Lee, Deborah P Burdsall, Robert Weinstein, Karen Trimberger, Mitali Shah, Mary K. Hayden, Mary Carl Froilan, William E. Trick, Stephanie R. Black, Anthony E. Fiore, Michael Schoeny, Marion Tseng, Elizabeth Soda, Sharon Foy, Michelle Ealy, Ellen Benson, Michael Y. Lin, Yingxu Xiang, Mary Alice Lavin
Publikováno v:
Infection Control & Hospital Epidemiology. 41:s48-s49
Background: Carbapenem-resistant Enterobacteriaceae (CRE) are endemic in the Chicago region. We assessed the regional impact of a CRE control intervention targeting high-prevalence facilities; that is, long-term acute-care hospitals (LTACHs) and vent